FomoMoFo1
Posted - 1 month ago
$TYRA not buying this is the biggest thing you will regret!!! BUY!
FomoMoFo1
Posted - 1 month ago
$TYRA buy this with all you might and money and thank me by the end of the week
BioStick123
Posted - 1 month ago
$URGN can anyone comment on whether $TYRA TYRA-300 is a competitor to UGN-102
TxSicario
Posted - 1 month ago
$TYRA is she running finally?
insiderbuyingselling
Posted - 1 month ago
$TYRA new insider selling: 11569 shares. http://insiderbuyingselling.com/?t=TYRA
insiderbuyingselling
Posted - 1 month ago
$TYRA new insider buying: 9500 shares. http://insiderbuyingselling.com/?t=TYRA
Maxton_B
Posted - 10/30/24
$TYRA ⚡️ Wild moves, no solid base. This one’s a gamble. Watch MYNZ! 75M EU, German-backed $1.5M, US deals teased. Petra Mainz hints BIG news. In 1-2 weeks, $10-50 & RS canceled.
swingingtech
Posted - 10/29/24
$XRX $TYRA $V
https://wallstreetwaves.com/tuesdays-highlighted-options-activity-xrx-tyra-v/
Fugazi_
Posted - 10/29/24
$TYRA news?
_www_larval_com_
Posted - 10/29/24
$ATNF 3%[6%] $AREB 3%[12%] $UAVS -3%[5%] $GREE 3%[17%] $TYRA -3%[-16%] most notable movement into the final minutes of trading.
BigBri217
Posted - 10/29/24
$TYRA wow. I really wish I had given the money I lost here away. Just terrible
VictorVVV
Posted - 10/29/24
$TYRA ai nvest data for Monday.
BigBri217
Posted - 10/28/24
$TYRA what is going on?
RealJamesGrove
Posted - 10/28/24
$SHIB.X $TYRA I’m in. This could get very interesting. 🤔
ChartLaboratory_com
Posted - 10/28/24
🚀 $TBBK is at $47.01! Watch for a potential bounce back to $50.00! 📈 www.patreon.com/chartlab 💡 $ANAB trading at $32.03! Look for a move toward $34.00! Don’t miss this chance! 🚀 www.patreon.com/chartlab 📈 $VIST just hit $52.93! Targeting a rise to $54.00! Keep an eye on this one! 🔍 www.patreon.com/chartlab 🌟 $TYRA at $21.93 with a potential recovery to $24.00! Watch closely! 🔥 www.patreon.com/chartlab 📊 $ZK moving at $28.85! Targeting a push to $30.00! Don't overlook this! 🔥 www.patreon.com/chartlab https://www.patreon.com/posts/chartlab-daily-114861855?utm_medium=clipboard_copy&utm_source=copyLink&utm_campaign=postshare_creator&utm_content=join_link
ChartLaboratory_com
Posted - 10/28/24
🚀 $EVLV is at $2.47! Watch for a potential target of $3.00! 📈 www.patreon.com/chartlab 🔥 $TTOO trading at $1.08! Aiming for $1.30 ahead! Don’t miss out! 🚀 www.patreon.com/chartlab 💡 $JOBY just hit $5.16! Targeting a bounce to $5.50! 📊 www.patreon.com/chartlab 📈 $MNPR at $16.93 with a bounce target of $18.00! Keep an eye on this one! 👀 www.patreon.com/chartlab 🌟 $TYRA is moving! Currently $21.93, aiming for $24.00! Don't overlook this! 🔍 www.patreon.com/chartlab
OpenOutcrier
Posted - 10/28/24
$TYRA (+5.3% pre) FDA clears Tyra Biosciences' trial for dwarfism drug - inv https://ooc.bz/l/45933
DonCorleone77
Posted - 10/28/24
$TYRA Tyra Biosciences granted IND clearance from FDA for Phase 2 study of Tyra-300 Tyra Biosciences announced that the FDA cleared its Investigational New Drug application for Tyra-300 allowing the company to proceed with a Phase 2 clinical trial of Tyra-300 for children with achondroplasia. TYRA-300 is a potential first-in-class, investigational, FGFR3-selective inhibitor designed to avoid the toxicities associated with inhibition of FGFR1, FGFR2 and FGFR4. Tyra-300 is also being evaluated for metastatic urothelial cancer in the ongoing SURF301 study. BEACH301 will be a Phase 2 study evaluating Tyra-300 in children ages 3 to 10 with achondroplasia with open growth plates. The primary objectives of this study will be to assess safety and tolerability in children with achondroplasia and evaluate change from baseline in annualized growth velocity to determine the dose for further development. Tyra is also planning exploratory assessments of clinical outcomes such as functional improvements, changes in the spine, and quality of life measures. In July 2023 and January 2024, the FDA granted Orphan Drug Designation and Rare Pediatric Designation to Tyra-300, respectively, for the treatment of achondroplasia.
justiceforb_85
Posted - 10/25/24
$TYRA wondering if the company will have a MOAT? Appears they are targeting some diseases (achondroplasia, bladder, urothelial carcinoma) with approved therapies...?
GambitMentality
Posted - 10/25/24
Today’s #StockMarket EOD Biggest Losers by %, led by $CPRI down 48%, $MNPR down 48%, and $TYRA down 23% to lead the TOP 3
BPharmCatalyst
Posted - 10/25/24
$ITRM announced that the FDA has approved Iterum's new drug application for ORLYNVAH (sulopenem etzadroxil and probenecid) for the treatment of uncomplicated urinary tract infections (uUTIs) Read more👇 https://www.biopharmcatalyst.com/news/2024/iterum-itrm-fda-approval-marinus-mrns-analyst $ITRM $MRNS $IBRX $LYEL $TYRA
BigBri217
Posted - 10/25/24
$TYRA why is this tanking?
RealJamesGrove
Posted - 10/25/24
$SHIB.X anyone else see this? 100% Buy? For $TYRA? 🤔
OpenOutcrier
Posted - 10/25/24
$TYRA (-4.2% pre) Tyra Biosciences Reports Interim Clinical Proof-of-Concept Data for TYRA-300, an Investigational Oral FGFR3-Selective Inhibitor, in Phase 1/2 SURF301 Study in Patients with Metastatic Urothelial Cance - SI https://ooc.bz/l/45771
themacromindset
Posted - 10/25/24
$TYRA Tyra Biosciences Reports Interim Clinical Proof-of-Concept Data for TYRA-300, an Investigational Oral FGFR3-Selective Inhibitor, in Phase 1/2 SURF301 Study in Patients with Metastatic Urothelial Cancer (mUC)
OpenOutcrier
Posted - 10/24/24
$TYRA (+7.9% pre) Tyra Biosciences to Host Conference Call on Interim Clinical Data of TYRA-300 from SURF301 Phase 1/2 Study on October 25, 2024, at 8am ET https://ooc.bz/l/45683
Fugazi_
Posted - 10/24/24
$TYRA data? Trading at 31.31
insiderbuyingselling
Posted - 1 month ago
$TYRA new insider selling: 62720 shares. http://insiderbuyingselling.com/?t=TYRA
PeedyWeedy
Posted - 1 month ago
$TYRA Is data on the 25th a big mover likely?
